These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29237956)

  • 1. Utility of the laminin immunohistochemical stain in distinguishing invasive from noninvasive urothelial carcinoma.
    Pradhan D; Amin M; Hooda S; Dhir R; Bastacky S; Parwani AV
    J Cancer Res Ther; 2017; 13(6):947-950. PubMed ID: 29237956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
    Abou Farha KM; Janknegt RA; Kester AD; Arends JW
    Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of muscularis mucosae in metastasis involvement of urinary bladder transitional cell carcinoma.
    Chaimuangraj S; Dissaranan C; Leenanupunth C; Prathombutr P; Chalermsanyakorn P
    J Med Assoc Thai; 2006 Sep; 89(9):1447-53. PubMed ID: 17100383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
    Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
    Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.
    Warrick JI; Hovelson DH; Amin A; Liu CJ; Cani AK; McDaniel AS; Yadati V; Quist MJ; Weizer AZ; Brenner JC; Feng FY; Mehra R; Grasso CS; Tomlins SA
    Virchows Arch; 2015 Mar; 466(3):297-311. PubMed ID: 25502898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of urothelial carcinoma.
    Rajcani J; Kajo K; Adamkov M; Moravekova E; Lauko L; Felcanova D; Bencat M
    Bratisl Lek Listy; 2013; 114(8):431-8. PubMed ID: 23944616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.